Clinical Trial Update: New Therapies and Biomarkers for Chagas Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on new therapies and biomarkers for Chagas disease, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Snippet

Sponsor: University of Texas, El Paso | Conditions: Trypanosoma Cruzi Infection, Chagas Disease | Phase 2 | Status: COMPLETED